or Try an Advanced Search...

    Investigational Stocks List

    Symbol Grade Name % Change
    BCDA D BioCardia, Inc. -1.04
    BIOR F Biora Therapeutics, Inc. -1.03
    DCTH C Delcath Systems, Inc. 8.76
    DVAX F Dynavax Technologies Corporation -1.51
    ESTA C Establishment Labs Holdings Inc. -2.40
    GLPG F Galapagos NV 0.27
    NERV F Minerva Neurosciences, Inc -1.90
    MIRM F Mirum Pharmaceuticals, Inc. -2.75
    MTEM F Molecular Templates, Inc. -3.33
    NAVB F Navidea Biopharmaceuticals, Inc. -13.33
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
    Related Stock Lists: Medicine Acid Biology Biopharmaceutical Biotechnology Clinical Development Hepatology Inflammatory Diseases Melanoma Oncology Parkinson's Disease Abdominal Pain Aesthetics Aging Associated Diseases Alzheimer's Disease Antidepressants Arthritis Asthma Autoimmune And Inflammatory Disease Autoimmune Disease

    Related ETFs - A few ETFs which own one or more of the above listed Investigational stocks.

    Symbol Grade Name Weight
    GERM C ETFMG Treatments Testing and Advancements ETF 3.59
    PBE C PowerShares Dynamic Biotech & Genome 2.44
    SBIO C ALPS Medical Breakthroughs ETF 1.99
    XBI C SPDR S&P Biotech ETF 1.75
    IDNA B iShares Genomics Immunology and Healthcare ETF 1.75
    View all Investigational ETFs...
    Compare ETFs
    Compare GERM to XBI Compare PBE to SBIO Compare XBI to IDNA

        Investigational Stocks Recent News

        Date Stock Title
        May 16 GLPG Galapagos creates new subscription right plans
        May 16 BIOR BIOR: BT-600 Data in June
        May 16 BIOR Biora Therapeutics Inc (BIOR) Q1 2024 Earnings Call Transcript Highlights: Navigating Through ...
        May 15 BIOR Biora Therapeutics, Inc. (BIOR) Q1 2024 Earnings Call Transcript
        May 15 GLPG Galapagos, BCA to collaborate on CAR-T cell therapy production
        May 15 BIOR Biora Therapeutics GAAP EPS of -$0.14 beats by $0.31, revenue of $0.54M
        May 15 BIOR Biora Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
        May 15 GLPG Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.
        May 15 BCDA BioCardia Inc (BCDA) Q1 2024 Earnings Call Transcript Highlights: Strategic Progress Amid ...
        May 15 DCTH Delcath Systems Inc (DCTH) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...
        May 15 BCDA BioCardia, Inc. (BCDA) Q1 2024 Earnings Call Transcript
        May 14 BCDA BioCardia GAAP EPS of -$0.09, revenue of $0.05M
        May 14 BCDA BioCardia Reports First Quarter 2024 Business Highlights and Financial Results
        May 14 DCTH Delcath Systems Inc (DCTH) Q1 2024 Earnings Call Transcript
        May 14 DVAX FDA Declines To Approve Expanded Use of Dynavax's Hepatitis B Vaccine In Hemodialysis Patients
        May 14 DVAX Dynavax down 5% on FDA Complete Response Letter for Heplisav-B for hemodialysis
        May 14 DVAX UPDATE 1-US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine
        May 14 DVAX Dynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B® Regimen for Adults on Hemodialysis in the U.S.
        May 14 DCTH Delcath Systems GAAP EPS of -$0.45 beats by $0.02, revenue of $3.14M beats by $0.95M
        May 14 DCTH Delcath Systems Reports First Quarter 2024 Results and Business Highlights
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Medical Devices
        Related Stock Lists: Medicine Acid Biology Biopharmaceutical Biotechnology Clinical Development Hepatology Inflammatory Diseases Melanoma Oncology Parkinson's Disease Abdominal Pain Aesthetics Aging Associated Diseases Alzheimer's Disease Antidepressants Arthritis Asthma Autoimmune And Inflammatory Disease Autoimmune Disease
        Investigational

        Browse All Tags